Tumor-infiltrating PD1-Positive Lymphocytes and FoxP3-Positive Regulatory T Cells Predict Distant Metastatic Relapse and Survival of Clear Cell Renal Cell Carcinoma - Wikidata - awgldk - TriplyDB

Tumor-infiltrating PD1-Positive Lymphocytes and FoxP3-Positive Regulatory T Cells Predict Distant Metastatic Relapse and Survival of Clear Cell Renal Cell Carcinoma

Tumor-infiltrating PD1-Positive Lymphocytes and FoxP3-Positive Regulatory T Cells Predict Distant Metastatic Relapse and Survival of Clear Cell Renal Cell Carcinoma

http://www.wikidata.org/entity/Q36865032

about

Programmed Cell Death-1 Polymorphisms Decrease the Cancer Risk: A Meta-Analysis Involving Twelve Case-Control Studies The effect of chemotherapy on programmed cell death 1/programmed cell death 1 ligand axis: some chemotherapeutical drugs may finally work through immune response The potential of radiotherapy to enhance the efficacy of renal cell carcinoma therapy Dissecting the Potential Interplay of DEK Functions in Inflammation and Cancer PD-1 as an emerging therapeutic target in renal cell carcinoma: current evidence Predictive and prognostic biomarkers of targeted agents and modern immunotherapy in renal cell carcinoma Prognostic significance of PD-L1 in solid tumor: An updated meta-analysis.An Immune Atlas of Clear Cell Renal Cell Carcinoma.The role of immunotherapy in solid tumors: report from the Campania Society of Oncology Immunotherapy (SCITO) meeting, Naples 2014 Tumor infiltrating PD1-positive lymphocytes and the expression of PD-L1 predict poor prognosis of soft tissue sarcomas Inhibitory Receptors Beyond T Cell Exhaustion.Expression of DNA Damage Response Molecules PARP1, γH2AX, BRCA1, and BRCA2 Predicts Poor Survival of Breast Carcinoma Patients.Individual and Combined Expression of DNA Damage Response Molecules PARP1, γH2AX, BRCA1, and BRCA2 Predict Shorter Survival of Soft Tissue Sarcoma Patients.Vascular endothelial growth factor A amplification in colorectal cancer is associated with reduced M1 and M2 macrophages and diminished PD-1-expressing lymphocytes Characterization of tumor infiltrating lymphocytes in paired primary and metastatic renal cell carcinoma specimens.The distribution of cutaneous metastases correlates with local immunologic milieu Harnessing the PD-1 pathway in renal cell carcinoma: current evidence and future directions The ratio of CD8 to Treg tumor-infiltrating lymphocytes is associated with response to cisplatin-based neoadjuvant chemotherapy in patients with muscle invasive urothelial carcinoma of the bladder.Coinhibitory molecule PD-1 as a potential target for the immunotherapy of multiple myeloma.Adoptive immunotherapy for cancer.Emerging roles of regulatory T cells in tumour progression and metastasis.New clinical advances in immunotherapy for the treatment of solid tumours.Role of PD-L1 expression as a biomarker for GEP neuroendocrine neoplasm grading.Programmed cell death ligand 1 and tumor-infiltrating lymphocyte status in patients with renal cell carcinoma and sarcomatoid dedifferentiation.Intratumoral expression of programmed death ligand 1 (PD-L1) in patients with clear cell renal cell carcinoma (ccRCC).HYPE or HOPE: the prognostic value of infiltrating immune cells in cancer.Prognostic significance of programmed cell death 1 (PD-1) or PD-1 ligand 1 (PD-L1) Expression in epithelial-originated cancer: a meta-analysis miR-28 modulates exhaustive differentiation of T cells through silencing programmed cell death-1 and regulating cytokine secretion.IL10 Release upon PD-1 Blockade Sustains Immunosuppression in Ovarian Cancer.Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Ca Clinicopathologic implications of CD8(+)/Foxp3(+) ratio and miR-574-3p/PD-L1 axis in spinal chordoma patients.Immune consequences of anti-angiogenic therapyin renal cell carcinoma.New treatment options for metastatic renal cell carcinoma.The PARP inhibitor olaparib potentiates the effect of the DNA damaging agent doxorubicin in osteosarcoma.Distribution and prognostic value of tumor‑infiltrating T cells in breast cancer Prediction of intravesical recurrence of non-muscle-invasive bladder cancer by evaluation of intratumoral Foxp3+ T cells in the primary transurethral resection of bladder tumor specimens

P2860

Q26749244-696693F5-091F-4AAA-8525-2E0DFA4B5EBB Q26766066-B3BA24F9-3938-4154-A0E8-CC593EC5F062 Q26783291-7CBF61F0-241B-46DE-B6F2-31BEAA193F94 Q26783559-0ED6363B-6EBD-417A-BF20-34B931E28629 Q26865789-92564E62-C9E5-477F-AC9A-923FE86612B5 Q28067482-D7CEB4C4-9A37-47B3-B144-FDD81C1E6FE1 Q33644049-0FE93443-3439-4041-930F-41C5E4E00DBC Q33649707-9D7D2C7D-E302-437A-9AED-62FD5A0ECB6E Q34402325-75F62D8B-1A11-41FF-AA1E-4EA5DD8708E4 Q35070603-AF89D6EF-4159-409A-A4B8-6B3CBC90A04B Q35783318-4E15507B-A621-4E9C-B518-C24C44D6CB65 Q36038008-2B81C070-B277-4294-9C4C-242129F641E1 Q36137287-032E6B52-D4B5-4795-A7DB-400796977F76 Q36344920-681D8423-F2A1-4D15-AB7E-8A912F1E0E26 Q36413093-AFB8EAE3-4E36-4730-B08B-8FBA45F881EC Q36600183-E685AFD7-3873-46D1-9518-6AA85FEA95AE Q36954166-F8F2F651-35F9-4929-94AA-74A577F77323 Q37012561-643BD7FC-C264-4013-9BEE-021FC3F3034E Q38155039-6958DD8B-CBAD-4CB2-816C-6660EDC4573E Q38170496-7655F5B3-DE61-4042-8948-568191DA1B07 Q38264092-DB3687D6-822A-4BAC-AB0D-26B6F1A84DED Q38397279-ADD35FE7-0F1E-47B9-80C4-5E705B8FF6DF Q38610333-7E6BED6C-638F-4009-A30A-5B5C70403F4E Q40498385-1E10F611-8474-430D-95C3-60BEE23B6450 Q40694190-32B091BE-5F8A-4E1F-BD30-8F8E20DC7E8D Q41431266-922E0E3B-CB72-4AEB-94EE-D195846DC06B Q41445876-C51119B7-A208-4D16-88FD-F6FCF68B9CB9 Q41992370-F9E8F589-14BE-46AD-960F-46A77EE2C826 Q45872969-7E40644E-AE97-477E-8E54-A7F0B20C1AA3 Q46540302-5CC1180A-C172-49AF-B253-C403C99099EC Q47756173-A6111137-0396-4D62-ABA0-83D24475AFCF Q54981236-022B4CF0-7544-48C0-AA66-9A2A653BD8D7 Q54990172-52546C9D-D7AD-40C4-840B-D71F0230CEFC Q55037005-8B796666-4327-4730-8776-E2C919E83A23 Q58762354-0078343F-5611-4238-A75F-4149A73A8F21 Q59129300-36BE7AD1-DF26-49E4-9AE3-955680871A4B

P2860

Tumor-infiltrating PD1-Positive Lymphocytes and FoxP3-Positive Regulatory T Cells Predict Distant Metastatic Relapse and Survival of Clear Cell Renal Cell Carcinoma

http://www.wikidata.org/entity/Q36865032

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Tumor-infiltrating PD1-Positiv ...... lear Cell Renal Cell Carcinoma

@en

type

label

Tumor-infiltrating PD1-Positiv ...... lear Cell Renal Cell Carcinoma

@en

prefLabel

Tumor-infiltrating PD1-Positiv ...... lear Cell Renal Cell Carcinoma

@en

P1433

Q36865032-2DB2BFEA-2ECB-4A42-9D4D-51847134A449

P1476

Q36865032-3C6EE9DF-C3E1-476D-B58E-7B52B6A552F3

P2093

Q36865032-1495736F-792F-4993-9B6A-4CA333ADB40C

Q36865032-2C888826-09BC-4E55-9898-F736B2F75FCE

Q36865032-5203A79C-EA6D-4093-9EC0-A6D5F1E1A3FB

Q36865032-599A3927-8B33-4B2C-8738-C482DBE65312

Q36865032-599D688C-1E3C-41E2-94A2-DB0C963036CC

Q36865032-A3910BB9-3EBF-4F24-991E-A82856405479

Q36865032-A9F2DEE3-7ABD-44F5-A508-A3D1380E07B1

Q36865032-CC3F509C-8554-4707-9D4F-02EFE4E25501

Q36865032-D75C6BCE-6A7F-4C20-9B74-076929A7274B

P2860

Q36865032-016EE5BB-8CB0-4F60-874A-5638B6F5F4E5

Q36865032-0196C116-C2EA-4B34-9A6E-D468C15FFA1A

Q36865032-1293902E-0F5E-4E9A-8D7C-B8C4162C7A53

Q36865032-14EB8603-B709-4987-B748-F38AEE4A6ED9

Q36865032-20BFA771-2DF8-4357-A4D6-224319C89DA1

Q36865032-33B01429-4B02-4999-98DF-2F5899156003

Q36865032-4CFEC2ED-05BD-42F8-9F24-49DBD7533507

Q36865032-52BF45A2-EBE3-4BD8-8221-8A45893EE375

Q36865032-5CA8B520-5DBC-44AF-8C32-B0C813C5B797

Q36865032-65C6B509-D492-4240-A8A0-DC16A5B7F2AE

P304

Q36865032-C981E075-0B4A-46A5-AAD7-15E7D9C8CB9D

P31

Q36865032-170B9E11-C748-46D7-B52A-AD5FB7F10C83

P356

Q36865032-48DEF2D4-2588-4005-8E6A-CCC57E8CE4EF

P433

Q36865032-4945E36B-5BAE-43A9-9C4F-474B2F6EDF0D

P478

Q36865032-55397DCD-4389-499D-A4FD-A6E050088E51

P577

Q36865032-8E0707C5-3653-4C6D-9760-5E722F31E4AC

P5875

Q36865032-05D0A933-781F-44A9-9D24-FA597641875F

P698

Q36865032-FB89180B-5969-4B6C-B195-A18CE41D7171

P932

Q36865032-5A74EB90-DA25-4B3E-AFA7-C8F4B56330CF

P356

P1433

Translational Oncology

P1476

Tumor-infiltrating PD1-Positiv ...... lear Cell Renal Cell Carcinoma

@en

P2093

Dong Geun Lee

http://www.w3.org/2001/XMLSchema#string

Ho Lee

http://www.w3.org/2001/XMLSchema#string

Ho Sung Park

http://www.w3.org/2001/XMLSchema#string

Jun Sang Bae

http://www.w3.org/2001/XMLSchema#string

Kyoung Min Kim

http://www.w3.org/2001/XMLSchema#string

Kyu Yun Jang

http://www.w3.org/2001/XMLSchema#string

Myoung Ja Chung

http://www.w3.org/2001/XMLSchema#string

Myoung Jae Kang

http://www.w3.org/2001/XMLSchema#string

Woo Sung Moon

http://www.w3.org/2001/XMLSchema#string

P2860

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer

Eradication of Epstein-Barr virus by allogeneic bone marrow transplantation: implications for sites of viral latency

Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation

Targeting regulatory T cells in cancer

PD-L2 is a second ligand for PD-1 and inhibits T cell activation

Localization of Epstein-Barr virus-encoded RNAs EBER-1 and EBER-2 in interphase and mitotic Burkitt lymphoma cells.

Systemic therapy for renal cell carcinoma.

Adjuvant therapy for locally advanced renal cell cancer: a systematic review with meta-analysis

Epstein-Barr virus infection of renal proximal tubule cells: possible role in chronic interstitial nephritis

Regulatory T cells in cancer.

P304

282-289

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1593/TLO.13256

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2013-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

237014701

http://www.w3.org/2001/XMLSchema#string

P698

23730407

http://www.w3.org/2001/XMLSchema#string

P932

3660796

http://www.w3.org/2001/XMLSchema#string